Ambrisentan and Tadalafil Up-Front Combination Therapy in Scleroderma-Associated Pulmonary Arterial Hypertension

American Journal of Respiratory and Critical Care Medicine - United States
doi 10.1164/rccm.201507-1398oc
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Thoracic Society

Related search

Tadalafil Therapy for Pulmonary Arterial Hypertension

Circulation
Cardiovascular MedicinePhysiologyCardiology
2009English

Pulmonary Arterial Hypertension Associated With Scleroderma

Advances in Pulmonary Hypertension
2008English

Up-Front Triple Combination Therapy for Pulmonary Arterial Hypertension Associated With Systemic Sclerosis: A Case Report

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2018English

Combination Targeted Pulmonary Hypertension Therapy in the Resolution of Dasatinib-Associated Pulmonary Arterial Hypertension

Pulmonary Circulation
PulmonaryRespiratory Medicine
2017English

Oral Tadalafil in Children With Pulmonary Arterial Hypertension

Drug Research
MedicineDrug Discovery
2015English

Scleroderma Associated Pulmonary Hypertension

Advances in Pulmonary Hypertension
2008English

Ambrisentan for the Treatment of Pulmonary Arterial Hypertension: Improving Outcomes

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2013English

Combination Therapies in Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2008English

Borderline Pulmonary Pressures in Scleroderma - A ‘Pre-Pulmonary Arterial Hypertension’ Condition?

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy